Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Steven Abman to Pulmonary Surfactants

This is a "connection" page, showing publications Steven Abman has written about Pulmonary Surfactants.

 
Connection Strength
 
 
 
0.574
 
  1. Kramer BW, Abman S, Daly M, Jobe AH, Niklas V. Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development. Paediatr Respir Rev. 2023 Dec; 48:24-29.
    View in: PubMed
    Score: 0.203
  2. Mandell E, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021 03; 56(3):661-669.
    View in: PubMed
    Score: 0.174
  3. Abman SH, Kinsella JP. Surfactant use in the term neonate with hypoxemic respiratory failure. J Pediatr. 1998 Nov; 133(5):716-7.
    View in: PubMed
    Score: 0.148
  4. Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol. 2019 06; 46(2):291-310.
    View in: PubMed
    Score: 0.038
  5. G?thberg S, Parker TA, Abman SH, Kinsella JP. High-frequency oscillatory ventilation and partial liquid ventilation after acute lung injury in premature lambs with respiratory distress syndrome. Crit Care Med. 2000 Jul; 28(7):2450-6.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)